Edward Mehr, CEO at Machina Labs, joins Cheddar to discuss artificial intelligence and robotics and how his company is working to utilize A.I. for equipment.

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

Imagine a system enabling transportation agencies to access and present roadway data more comprehensively and visually.

A breakthrough in Structural Health Monitoring: the iKS3 element reduces sensor needs for thin-walled structures while ...

By Ayo Ashubiojo Most aspects of human life are impacted by machine learning. The analytics of data gathered from various ...

An AI tool that analyzes nurses' data and notes detected when patients in the hospital were deteriorating nearly two days earlier than traditional methods and reduced the risk of death by over 35%, ...

HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 ...

Monitoring urban plant health traditionally requires extensive manual labor and botanical expertise, creating challenges for ...

Agentic AI is quickly becoming the next target for healthcare leaders as they integrate current technologies successfully and look for even better outcomes. Many academic health systems are beginning ...